Clinical analysis of combination chemotherapy for advanced and recurrent gastric cancer with 5-fluorouracil (5-FU) and cis-diamminedichloroplatinum (CDDP)

被引：0
|
作者：
Mochizuki, F
Fujii, M
Kasakura, Y
Kanamori, N
Kochi, M
Tani, M
Otsuka, Y
Yamagata, M
Iwai, S
机构：
来源：
PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS | 1997年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Combination chemotherapy with 5-fluorouracil (5-FU) and cis-diamminedichloroplatinum (CDDP) was given to 16 patients in advanced and recurrent gastric cancer. The regimen consisted of 5-FU 1000 mg/m(2) (day 1-5, continuous infusion) and CDDP 100 mg/m(2) (day 3, 1 hr. drip infusion). The interval was from the 6th day to the 21st day. Sixteen patients were evaluated. In the treated cases, ten patients were regarded as partial response (PR) and six as no change (NC). Overall response rate was 62.5% (10/16). Three of the sixteen patients were now surviving. The longest survival period was 17.3 months. The average survival period was 8.61 months. Adverse reactions were severe leukocytopenia, thrombocytopenia, mild stomatitis, nausea, vomiting. alopecia. renal dysfunction and peripheral neuropathy. This therapy is thought to be effective against advanced and recurrent gastric cancer.
引用
收藏
页码：1559 / 1563
页数：5
相关论文
共 50 条
  • [31] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [32] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [33] SURVIVAL OF PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER TREATED WITH 5-FLUOROURACIL (5-FU) DRIP
    GRILLOLOPEZ, AJ
    VELEZGARCIA, E
    ELLIOTT, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 331 - 331
  • [34] METABOLISM OF 5-FLUOROURACIL (5-FU) IN HUMAN GASTROINTESTINAL CANCER
    BERNE, M
    ALMERSJO, O
    GUSTAVSSON, B
    ACTA CHIRURGICA SCANDINAVICA, 1983, : 31 - 31
  • [35] Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
    Falcone, A
    Pfanner, E
    Brunetti, I
    Allegrini, G
    Lencioni, M
    Galli, C
    Masi, G
    Danesi, D
    Antonuzzo, A
    Del Tacca, M
    Conte, PF
    TUMORI, 1998, 84 (06) : 666 - 668
  • [36] Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer
    Sohda, Makoto
    Hara, Keigo
    Kuriyama, Kengo
    Tateno, Kouhei
    Uchida, Shintaro
    Watanabe, Takayoshi
    Shibasaki, Yuta
    Saito, Hideyuki
    Nakazawa, Nobuhiro
    Sano, Akihiko
    Sakai, Makoto
    Yokobori, Takehiko
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2024, 44 (03) : 1309 - 1315
  • [37] COMBINATION CHEMOTHERAPY OF HEPATOCELLULAR CARCINOMA (HC) WITH 5-FLUOROURACIL (5-FU) AND MITOMYCIN-C (MMC)
    UMSAWASDI, T
    CHAINUVATI, T
    VIRANUVATTI, V
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 193 - 193
  • [38] COMBINATION OF 5-FLUOROURACIL(5-FU) PLUS SEMUSTINE(MECCNU) WITH AND WITHOUT RADIOTHERAPY (RT) IN ADVANCED GASTRIC AND PANCREATIC-CARCINOMA
    THIRLWELL, MP
    KEABLE, HE
    KOST, K
    HAZEL, JJ
    MAKSYMIUK, AW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 449 - 449
  • [39] GEMCITABINE (GEM) PLUS OXALIPLATIN, FOLINIC ACID (FA) AND 5-FLUOROURACIL (5-FU) IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Correale, Pierpaolo
    Fulfaro, Fabio
    Cicero, Giuseppe
    Bajardi, Emilio
    Marsili, Stefania
    Petrioli, Roberto
    Vuolo, Giuseppe
    Guarnieri, Alfredo
    Gebbia, Nicola
    Francini, Guido
    ANNALS OF ONCOLOGY, 2004, 15 : 70 - 71
  • [40] Randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP, 5-FU and dl-leucovorin for advanced colorectal cancer
    Okabe, S
    Arai, T
    Yamashita, H
    Sugihara, K
    Sasaki, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (01) : 56 - 62
12345